ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $322 | -24.1% | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $424 | +15.5% | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $367 | -63.3% | 48 | -73.8% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 183 | -3.2% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 189 | -65.3% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -11.1% | 544 | +74.9% | 0.00% | -50.0% |
| Q4 2021 | $9,000 | +50.0% | 311 | +75.7% | 0.00% | +100.0% |
| Q3 2021 | $6,000 | +50.0% | 177 | +88.3% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -66.7% | 94 | -50.5% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +200.0% | 190 | +134.6% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | +300.0% | 81 | +179.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |